Browsing Centre for Preventative Neurology by Title
Now showing items 73-92 of 137
-
Management of Possible Multiple Sclerosis.
(2023-06-08) -
The Motor Dysfunction Seen in Isolated REM Sleep Behavior Disorder.
(2024-03-12)BACKGROUND: Isolated Rapid Eye Movement (REM) sleep Behavior Disorder (iRBD) requires quantitative tools to detect incipient Parkinson's disease (PD). METHODS: A motor battery was designed and compared with the Movement ... -
Multi-ancestry genome-wide association meta-analysis of Parkinson's disease.
(2024-01)Although over 90 independent risk variants have been identified for Parkinson's disease using genome-wide association studies, most studies have been performed in just one population at a time. Here we performed a large-scale ... -
Multiple sclerosis, disease modifying therapies and pregnancy
(Mark Allen Group, 2022-07-01) -
Myelin Oligodendrocyte Glycoprotein-Antibody Associated Disease: An Updated Review of the Clinical Spectrum, Pathogenetic Mechanisms and Therapeutic Management
(MDPI, 2024-05-17)Clinical syndromes associated with antibodies against myelin oligodendrocyte glycoprotein (MOG) are now recognized as a distinct neurological disease entity, and are gaining increasing attention. The pathogenic mechanisms ... -
Navigating a world of big data, machine learning and artificial intelligence: a neurologist's guide
(BMJ Publishing Group, 2020-09-29) -
Nitrous oxide and its neurological harms.
(2023-10) -
No evidence for a causal relationship between cancers and Parkinson’s disease
(IOS Press, 2021-02-23) -
Parkinson's disease age at onset genome‐wide association study: Defining heritability, genetic loci, and α‐synuclein mechanisms
(Wiley, 2019-04-07)Background: Increasing evidence supports an extensive and complex genetic contribution to PD. Previous genome‐wide association studies (GWAS) have shed light on the genetic basis of risk for this disease. However, the ... -
Parkinson's disease age at onset genome‐wide association study: Defining heritability, genetic loci, and α‐synuclein mechanisms
(Wiley, 2019-04-07)Background: Increasing evidence supports an extensive and complex genetic contribution to PD. Previous genome‐wide association studies (GWAS) have shed light on the genetic basis of risk for this disease. However, the ...